Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC

Autor:	Joanna Roder, Heinrich Roder, Egbert F. Smit, Joachim G.J.V. Aerts, Mirte Muller, C. Oliveira, Anna-Larissa N. Niemeijer
Přispěvatelé:	Pulmonary medicine
Jazyk:	angličtina
Rok vydání:	2018
Předmět:	0301 basic medicine Oncology medicine.medical_specialty Primary (chemistry) business.industry Hematology 03 medical and health sciences 030104 developmental biology Second line Internal medicine medicine Anti pd1 business
Zdroj:	Smit, E F, Aerts, J G, Muller, M, Niemeijer, A L N, Roder, H, Oliveira, C & Roder, J 2018, ' Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii21 . https://doi.org/10.1093/annonc/mdy269.068 Annals of oncology : official journal of the European Society for Medical Oncology, 29. Oxford University Press
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8f3621c294b48335d2753e3ad445f6 http://www.scopus.com/inward/record.url?scp=85078829722&partnerID=8YFLogxK Zobrazit plný text záznamu